feed,title,long_url,short_url
Investing,"B. Riley downgrades Genesco to Neutral, shares slide",https://www.investing.com/news/stock-market-news/b-riley-downgrades-genesco-to-neutral-shares-slide-432SI-3325340,https://da.gd/PitO
Investing,Target shares get a boost with raised price target to $195,https://www.investing.com/news/stock-market-news/target-shares-get-a-boost-with-raised-price-target-to-195-93CH-3325342,https://da.gd/66066
Investing,Latest J&J talc trial ends with hung jury,https://www.investing.com/news/stock-market-news/latest-jj-talc-trial-ends-with-hung-jury-3325341,https://da.gd/KYd09
Investing,"Piper Sandler cuts Milestone Pharma stock target to $5, keeps Overweight",https://www.investing.com/news/stock-market-news/piper-sandler-cuts-milestone-pharma-stock-target-to-5-keeps-overweight-93CH-3325339,https://da.gd/IPMXRA
Investing,Avadel shares rise as Oppenheimer lifts price target to $29,https://www.investing.com/news/stock-market-news/avadel-shares-rise-as-oppenheimer-lifts-price-target-to-29-93CH-3325337,https://da.gd/a52yU
Investing,Synovus appoints fintech expert as payments chief,https://www.investing.com/news/stock-market-news/synovus-appoints-fintech-expert-as-payments-chief-93CH-3325336,https://da.gd/1ZjxcD
Investing,Dyne Therapeutics stock target raised to $47 on promising data,https://www.investing.com/news/stock-market-news/dyne-therapeutics-stock-target-raised-to-47-on-promising-data-93CH-3325329,https://da.gd/X5qSp
